L-type calcium current reactivation contributes to arrhythmogenesis associated with action potential triangulation

Journal of Cardiovascular Electrophysiology

Volumn 18, Issue 2, 2007, Pages 196-203

  Guo, Donglin ^a   Zhao, Xiaojing ^a   Wu, Ying ^a   Liu, Tengxian ^a   Kowey, Peter R ^a,b   Yan, Gan Xin ^a,b  

^a Main Line Health Heart Center   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Action potential; L type calcium currents; Proarrhythmic; Triangulation

Indexed keywords

CALCIUM CHANNEL L TYPE;

ANIMAL CELL; ARRHYTHMOGENESIS; ARTICLE; CALCIUM CURRENT; CONTROLLED STUDY; GUINEA PIG; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART MUSCLE FIBER MEMBRANE POTENTIAL; HEART REPOLARIZATION; MICROELECTRODE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RECORDING; VOLTAGE CLAMP; WAVEFORM;

ACTION POTENTIALS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; GUINEA PIGS; IMIDAZOLIDINES; MYOCYTES, CARDIAC; NICARDIPINE; PATCH-CLAMP TECHNIQUES; PHENETHYLAMINES; PIPERAZINES; RABBITS; SULFONAMIDES;

EID: 33846347308     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2006.00698.x     Document Type: Article

References (40)

1. Selzer A, Wray HW: Quinidine syncope: Paroxysmal ventricular fibrillation occurring during treatment of chronic atrial arrhythmias. Circulation 1964;30:17-26.
2. Lasser KE, Allen PD, Woolhandler SJ, Himmelstein DU, Wolfe SM, Bor DH: Timing of new black box warnings and withdrawals for prescription medications. JAMA 2002;287:2215-2220.
3. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med 2004;350:1013-1022.
4. van Opstal JM, Schoenmakers M, Verduyn SC, de Groot SH, Leunissen JD, Der Hulst FF, Molenschot MM, Wellens HJ, Vos MA: Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome. Circulation 2001;104:2722-2727.
5. Milberg P, Eckardt L, Bruns HJ, Biertz J, Ramtin S, Reinsch N, Fleischer D, Kirchhof P, Fabritz L, Breithardt G, Haverkamp W: Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: Fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes. J Pharmacol Exp Ther 2002;303:218-225.
6. Winslow E, Campbell JK, Marshall RJ: Comparative electrophysiological effects of disopyramide and bepridil on rabbit atrial, papillary, and Purkinje tissue: Modification by reduced extracellular potassium. J Cardiovasc Pharmacol 1986;8:1208-1216.
7. Nobe S, Aomine M, Arita M: Bepridil prolongs the action potential duration of guinea pig ventricular muscle only at rapid rates of stimulation. Gen Pharmacol 1993;24:1187-1196.
8. Yan GX, Antzelevitch C: Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome. Circulation 1998;98:1928-1936.
9. Yan GX, Wu Y, Liu T, Wang J, Marinchak RA, Kowey PR: Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome: Direct evidence from intracellular recordings in the intact left ventricularwall. Circulation 2001;103:2851-2856.
10. Murakawa Y, Sezaki K, Yamashita T, Kanese Y, Omata M: Three-dimensional activation sequence of cesium-induced ventricular arrhythmias. Am J Physiol 1997;273:H1377-H1385.
11. Antzelevitch C, el Sherif N, Rosenbaum D, Vos M: Cellular mechanisms underlying the long QT syndrome. J Cardiovasc Electrophysiol 2003;14:114-115.
12. Yan GX, Joshi A, Guo D, Hlaing T, Martin J, Xu X, Kowey PR: Phase 2 reentry as a trigger to initiate ventricular fibrillation during early acute myocardial ischemia. Circulation 2004;110:1036-1041.
13. Luo CH, Rudy Y: A model of the ventricular cardiac action potential. Depolarization, repolarization, and their interaction. Circ Res 1991;68:1501-1526.
14. Viswanathan PC, Rudy Y: Pause induced early afterdepolarizations in the long QT syndrome: A simulation study. Cardiovasc Res 1999;42:530-542.
15. Luo CH, Rudy Y: A dynamic model of the cardiac ventricular action potential. I. Simulations of ionic currents and concentration changes. Circ Res 1994;74:1071-1096.
16. Hondeghem LM, Carlsson L, Duker G: Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic. Circulation 2001;103:2004-2013.
17. Valentin JP, Hoffmann P, De Clerck F, Hammond TG, Hondeghem L: Review of the predictive value of the Langendorff heart model (Screenit system) in assessing the proarrhythmic potential of drugs. J Pharmacol Toxicol Methods 2004;49:171-181.
18. Lu HR, Vlaminckx E, Van Ammel K, De Clerck F: Drug-induced long QT in isolated rabbit Purkinje fibers: Importance of action potential duration, triangulation and early afterdepolarizations. Eur J Pharmacol 2002;452:183-192.
19. Champeroux P, Viaud K, El Amrani AI, Fowler JS, Martel E, Le Guennec JY, Richard S: Prediction of the risk of Torsade de Pointes using the model of isolated canine Purkinje fibres. Br J Pharmacol 2005;144:376-385.
20. Rials SJ, Wu Y, Xu X, Filart RA, Marinchak RA, Kowey PR: Regression of left ventricular hypertrophy with captopril restores normal ventricular action potential duration, dispersion of refractoriness, and vulnerability to inducible ventricular fibrillation. Circulation 1997;96:1330-1336.
21. Boutjdir M, Restivo M, Wei Y, Stergiopoulos K, el Sherif N: Early afterdepolarization formation in cardiac myocytes: Analysis of phase plane patterns, action potential, and membrane currents. J Cardiovasc Electrophysiol 1994;5:609-620.
22. Zeng J, Rudy Y: Early afterdepolarizations in cardiac myocytes: Mechanism and rate dependence. Biophys J 1995;68:949-964.
23. Patterson E, Scherlag BJ, Lazzara R: Early afterdepolarizations produced by d,l-sotalol and clofilium. J Cardiovasc Electrophysiol 1997;8:667-678.
24. Matsuda T, Kurata Y: Effects of nicardipine and bupivacaine on early after depolarization in rabbit sinoatrial node cells: A possible mechanism of bupivacaine-induced arrhythmias. Gen Pharmacol 1999;33:115-125.
25. Hondeghem LM, Dujardin K, De Clerck F: Phase 2 prolongation, in the absence of instability and triangulation, antagonizes class III proarrhythmia. Cardiovasc Res 2001;50:345-353.
26. Sugiyama A: Effects of clinically available drugs on the repolarization process of the heart assessed by the in vivo canine models. Nippon Yakurigaku Zasshi 2003;121:393-400.
27. Shah RR, Hondeghem LM: Refining detection of drug-induced proarrhythmia: QT interval and TRIaD. Heart Rhythm 2005;2:758-772.
28. Szabo B, Sweidan R, Rajagopalan CV, Lazzara R: Role of Na+:Ca2+ exchange current in Cs(+)-induced early afterdepolarizations in Purkinje fibers. J Cardiovasc Electrophysiol 1994;5:933-944.
29. Zygmunt AC, Goodrow RJ, Weigel CM: INaCa and ICl(Ca) contribute to isoproterenol-induced delayed after depolarizations in midmyocardial cells. Am J Physiol 1998;275:H1979-H1992.
30. Spencer CI, Sham JS: Effects of Na+/Ca2+ exchange induced by SR Ca2+ release on action potentials and afterdepolarizations in guinea pig ventricular myocytes. Am J Physiol Heart Circ Physiol 2003;285:H2552-H2562.
31. Starmer CF, Grant AO, Colatsky TJ: What happens when cardiac Na channel function is compromised? 2. Numerical studies of the vulnerable period in tissue altered by drugs. Cardiovasc Res 2003;57:1062-1071.
32. Kimura J, Miyamae S, Noma A: Identification of sodium-calcium exchange current in single ventricular cells of guinea-pig. J Physiol 1987;384:199-222.
33. Janvier NC, Boyett MR: The role of Na-Ca exchange current in the cardiac action potential. Cardiovasc Res 1996;32:69-84.
34. Lazzara R: Mechanistic and clinical aspects of acquired long QT syndromes. Ann N Y Acad Sci 1992;644:48-56.
35. Kass RS, Sanguinetti MC: Inactivation of calcium channel current in the calf cardiac Purkinje fiber. Evidence for voltage- and calcium-mediated mechanisms. J Gen Physiol 1984;84:705-726.
36. Sanguinetti MC, Krafte DS, Kass RS: Voltage-dependent modulation of Ca channel current in heart cells by Bay K8644. J Gen Physiol 1986;88:369-392.
37. Milberg P, Ramtin S, Monnig G, Osada N, Wasmer K, Breithardt G, Haverkamp W, Eckardt L: Comparison of the in vitro electrophysiologic and proarrhythmic effects of amiodarone and sotalol in a rabbit model of acute atrioventricular block. J Cardiovasc Pharmacol 2004;44:278-286.
38. Xu X, Rials SJ, Wu Y, Salata JJ, Liu T, Bharucha DB, Marinchak RA, Kowey PR: Left ventricular hypertrophy decreases slowly but not rapidly activating delayed rectifier potassium currents of epicardial and endocardial myocytes in rabbits. Circulation 2001;103:1585-1590.
39. Haider AW, Larson MG, Benjamin EJ, Levy D: Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol 1998;32:1454-1459.
40. Lu HR, Marien R, Saels A, De Clerck F: Species plays an important role in drug-induced prolongation of action potential duration and early afterdepolarizations in isolated Purkinje fibers. J Cardiovasc Electrophysiol 2001;12:93-102.